Replies to post #72869 on NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

"Hey, wait! Don't forget AstraZeneca's checkpoint inhibitor

At the very outset (2 weeks ago) I DID include Astra Zeneca: it is #7 in the NWBO STICKY: Collection of Expert Interviews:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124942557

as one of the authors of that study has impact at Astra Zeneca:

Disclosure of Potential Conflicts of Interest
R.E. Hollingsworth is a senior director, oncology and has ownership interest
(including patents) in MedImmune.-very expensive acquisition yrs ago of Astra's No potential conflicts of interest were disclosed by the other authors

.

As for the "overflow": it may have to wait as internal manpower at NWBO has been likely stretched to it's max.

GSK a favorite of Woodford and UK'ers ...... well I must confess I overlooked!

Still more than befuddles and IRKS me that Larry Smith latest report was a DOWNER. Those who feel differently have NOT been in the business and duking it out professionally for decades versus just a "passive" stockholder who has been buried for a reason vs blaming CEO Linda Powers. And he was on the All Star Team of Analysts of Institutional Investor All Star Team for Big Rx's and first to recommend AMGN, who interviewed me for Smith Barney's Research Dept, would spend the last 18 months plus with what I said would be an unproductive use of one's time dealing with regulators (the whole naked short side etc) as well as it is an ant vs an elephant war (fighting the AF/Manipulator $Multi BILLIONS and entrenched for last 20 yrs!)) along with NO response on presenting NWBO in it's prime Late Summer 2014 to Baker Bros. Well IMHO that's what the record and facts shows what happens with those who do not have an open mind IMHO! Similarly can be said on this site.

All are awaiting with abated breathe for REALITY.

Until then, only approximately a handful of us are brazen enough to stand up and call it as we see it as: Never easy to debunk the conventional wisdom or go against the crowd, along with taking a LARGE position.